Ligand Pharm (LGND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 34,228 | 86,139 | 52,154 | 33,966 | 44,239 |
| Depreciation Amortization | 17,211 | 8,692 | 35,443 | 25,943 | 17,680 |
| Income taxes - deferred | -1,120 | 19,546 | 11,696 | 6,761 | -1,246 |
| Accounts receivable | -5,587 | 3,462 | -2,601 | -5,436 | 2,476 |
| Other Working Capital | 633 | 8,243 | -34,402 | -18,411 | 2,421 |
| Other Operating Activity | -13,319 | -107,350 | -12,713 | -1,311 | -31,704 |
| Operating Cash Flow | $32,046 | $18,732 | $49,577 | $41,512 | $33,866 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 20,444 | -2,171 | 67,403 | 26,997 | 20,509 |
| PPE Investments | -4,687 | -105 | -53,849 | -3,104 | -2,617 |
| Net Acquisitions | N/A | N/A | -10,405 | -10,405 | N/A |
| Purchase Of Investment | -998 | -998 | -15,249 | -15,235 | N/A |
| Purchase Sale Intangibles | 4,207 | -501 | 418 | 349 | 213 |
| Other Investing Activity | -73,293 | -501 | 418 | 349 | 213 |
| Investing Cash Flow | $-58,534 | $-3,775 | $-11,682 | $-1,398 | $18,105 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -5 | -76,854 | -40 | -76,854 |
| Common Stock Issued | 24,856 | 15,304 | 22,448 | 15,922 | 12,535 |
| Common Stock Repurchased | N/A | N/A | N/A | -76,854 | N/A |
| Other Financing Activity | -3,183 | -3,117 | -5,541 | -4,290 | -4,213 |
| Financing Cash Flow | $21,673 | $12,182 | $-59,947 | $-65,262 | $-68,532 |
| Beginning Cash Position | 22,954 | 22,954 | 45,006 | 45,006 | 45,006 |
| End Cash Position | 18,139 | 50,093 | 22,954 | 19,858 | 28,445 |
| Net Cash Flow | $-4,815 | $27,139 | $-22,052 | $-25,148 | $-16,561 |
| Free Cash Flow | |||||
| Operating Cash Flow | 32,046 | 18,732 | 49,577 | 41,512 | 33,866 |
| Capital Expenditure | -4,687 | -105 | -53,849 | -3,104 | -2,617 |
| Free Cash Flow | 27,359 | 18,627 | -4,272 | 38,408 | 31,249 |